A dose-sparing intradermal mpox vaccination regimen was safe and generated an antibody response equivalent to that induced by ...
KINSHASA, Congo (AP) — Congo is struggling to contain its biggest mpox outbreak, and scientists say a new form of the disease ...
A one-fifth dose of Bavarian Nordic’s mpox vaccine Jynneos can elicit a similar antibody response as its standard-dose regimen, according to findings presented Saturday at the European Society of ...
Lower dose of monkeypox vaccine is found to be safe with equal six-week antibody response, promising for vaccination strategies.
The effectiveness of vaccines against the new variant remains unknown, although animal data shows promising results.
A cluster of mpox cases in the Democratic Republic of the Congo sparks worries of a wider outbreak. A virulent strain of the ...
World Immunization Week: 507 vaccines in late-stage development, 88 using mRNA tech to prevent TB, malaria, flu, COVID-19, ...
Chemical biologists design an early 'proof-of-concept' vaccine that could lead to the first effective treatment of xylazine overdose in people. Xylazine is an FDA-approved sedative and pain ...
The Food and Drug Administration has accepted for review the Biologics License Application for GSK’s 5-in-1 meningococcal ABCWY (MenABCWY) vaccine candidate ... as 2 doses 6 months apart ...
Labcorp (NYSE:LH) announced Wednesday that the U.S. Food and Drug Administration (FDA) granted emergency use authorization for its Mpox PCR Test Home Collection Kit, which can be used to detect ...
With a final decision expected next February, MenABCWY combines the protective elements of GSK’s existing vaccines to target the five primary serogroups of Neisseria meningitidis. GSK announced that ...
Volunteers are being sought to test a new mRNA vaccine for mpox, formerly known as monkeypox ... be randomly selected to receive one of three dose levels of the vaccine, or a placebo.